Camilo Colaco
27Patents
17h-index
20Co-inventors
81Inventor score
Filing activity: Jun 8, 1994 → Feb 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6811792B2 | Solid dose delivery vehicle and methods of making same | Emerging Cross-Sectional Technologies | 206 | Expired |
| US6290991A | Solid dose delivery vehicle and methods of making same | Emerging Cross-Sectional Technologies | 159 | Expired |
| US7056495B2 | Solid dose delivery vehicle and methods of making same | Emerging Cross-Sectional Technologies | 140 | Expired |
| US6586006B2 | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same | Emerging Cross-Sectional Technologies | 138 | Expired |
| US6565871B2 | Solid dose delivery vehicle and methods of making same | Emerging Cross-Sectional Technologies | 128 | Expired |
| US6313102A | Method for stabilization of biological substances during drying and subsequent storage and compositions thereof | Emerging Cross-Sectional Technologies | 126 | Expired |
| US5955448A | Method for stabilization of biological substances during drying and subsequent storage and compositions thereof | Emerging Cross-Sectional Technologies | 111 | Expired |
| US6331310A | Solid dose delivery vehicle and methods of making same | Emerging Cross-Sectional Technologies | 106 | Expired |
| US5621094A | Method of preserving agarose gel structure during dehydration by adding a non-reducing glycoside of a straight-chain sugar alcohol | Chemistry; Metallurgy | 49 | Expired |
| US6517860B1 | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery | Human Necessities | 47 | Expired |
| US5958455A | Oral solid dosage forms, methods of making same and compositions thereof | Human Necessities | 43 | Expired |
| US6468782B1 | Methods of preserving prokaryotic cells and compositions obtained thereby | Chemistry; Metallurgy | 41 | Expired |
| US6893657B2 | Solid dose delivery vehicle and methods of making same | Emerging Cross-Sectional Technologies | 31 | Expired |
| US7785631B2 | Solid dose delivery vehicle and methods of making same | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6034080A | Use of Maillard reaction inhibitors for the treatment of amyloidosis-based disease | Human Necessities | 23 | Expired |
| US5891873A | Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease | Human Necessities | 20 | Expired |
| US6890512B2 | Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby | Emerging Cross-Sectional Technologies | 19 | Expired |
| US7744925B2 | Solid dose delivery vehicle and methods of making same | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6194001A | Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient | Human Necessities | 11 | Expired |
| US6455511B1 | Compositions for use in rehydration and nutrition during athletic exercise and methods of making same | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7780991B2 | Solid dose delivery vehicle and methods of making same | Emerging Cross-Sectional Technologies | 6 | Expired |
| US9593143B2 | Method for purifying protein complexes | Emerging Cross-Sectional Technologies | 4 | Active |
| US7494785B1 | Recombinant subunit vaccine | Chemistry; Metallurgy | 3 | Expired |
| US10240179B2 | Method for the production of protein complexes and vaccine compositions comprising the same | Emerging Cross-Sectional Technologies | 1 | Active |
| US6596702B2 | Compositions for use in rehydration and nutrition during athletic exercise and methods of making same | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.